🇺🇸 FDA
Pipeline program

FOLFIRI

E7820-702

Phase 2 small_molecule terminated

Quick answer

FOLFIRI for Colon Cancer is a Phase 2 program (small_molecule) at Eisai Co., with 1 ClinicalTrials.gov record(s).

Program details

Company
Eisai Co.,
Indication
Colon Cancer
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials